Variant report
Variant | nsv524095 |
---|---|
Chromosome Location | chr9:12672097-12677412 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr9:12607055..12609983-chr9:12671838..12674027,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1408799 | chr9:12672097-12672098 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundancedisease |
2 | rs552995226 | chr9:12672112-12672113 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs116056014 | chr9:12672121-12672122 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs62538946 | chr9:12672130-12672131 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs564965952 | chr9:12672146-12672147 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs374654001 | chr9:12672154-12672155 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs192997786 | chr9:12672155-12672156 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs367895087 | chr9:12672209-12672210 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs182514824 | chr9:12672213-12672214 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs148401089 | chr9:12672246-12672247 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs529909043 | chr9:12672250-12672251 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs568140772 | chr9:12672260-12672261 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs1408800 | chr9:12672275-12672276 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs537296003 | chr9:12672301-12672302 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs1408801 | chr9:12672320-12672321 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs551446695 | chr9:12672324-12672325 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs571617332 | chr9:12672345-12672346 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs537653384 | chr9:12672357-12672358 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs557231268 | chr9:12672379-12672380 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs9919017 | chr9:12672396-12672397 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs536942433 | chr9:12672405-12672406 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs187982303 | chr9:12672480-12672481 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs193047952 | chr9:12672484-12672485 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs144008343 | chr9:12672486-12672487 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs376035448 | chr9:12672571-12672572 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs185756104 | chr9:12672576-12672577 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs146448161 | chr9:12672604-12672605 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs140929755 | chr9:12672609-12672610 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs188905744 | chr9:12672727-12672728 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs79286117 | chr9:12672736-12672737 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs536254364 | chr9:12672739-12672740 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs77306624 | chr9:12672741-12672742 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs79537851 | chr9:12672754-12672755 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs192163782 | chr9:12672848-12672849 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs528484224 | chr9:12672901-12672902 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs184712898 | chr9:12672927-12672928 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs144366978 | chr9:12672929-12672930 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs530898984 | chr9:12673008-12673009 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs118035917 | chr9:12673031-12673032 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs151092629 | chr9:12673044-12673045 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs141073290 | chr9:12673117-12673118 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs553717269 | chr9:12673124-12673125 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs10809820 | chr9:12673237-12673238 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs538643150 | chr9:12673238-12673239 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs150270347 | chr9:12673248-12673249 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs575341365 | chr9:12673250-12673251 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs111753866 | chr9:12673281-12673282 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs77687584 | chr9:12673293-12673294 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs397894104 | chr9:12673296-12673297 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs537543043 | chr9:12673302-12673303 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
abnormal development | 18461090 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Cancer | 20164920 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 22183965 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 21611746 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:12671800-12672600 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr9:12672600-12675400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr9:12674400-12676400 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
4 | chr9:12675400-12675600 | Flanking Active TSS | Foreskin Melanocyte Primary Cells skin03 | Skin |
5 | chr9:12675600-12677400 | Active TSS | Foreskin Melanocyte Primary Cells skin03 | Skin |
6 | chr9:12676400-12681000 | Active TSS | Foreskin Melanocyte Primary Cells skin01 | Skin |
7 | chr9:12677400-12677800 | Flanking Active TSS | Foreskin Melanocyte Primary Cells skin03 | Skin |